All Stories

  1. Recent advances in the molecular landscape of lung neuroendocrine tumors

    Article • Expert Review of Molecular Diagnostics, March 2019, Taylor & Francis

    Sergio Harari

  2. The prognostic role of Gender-Age-Physiology system in idiopathic pulmonary fibrosis patients treated with pirfenidone

    Article • The Clinical Respiratory Journal, March 2019, Wiley

    Sergio Harari

  3. The association between air pollution and the incidence of idiopathic pulmonary fibrosis in Northern Italy

    Article • European Respiratory Journal, January 2018, European Respiratory Society (ERS)

    Sergio Harari

  4. Pulmonary hypertension: a paradigm for rare pulmonary diseases

    Article • European Respiratory Review, December 2017, European Respiratory Society (ERS)

    Sergio Harari

  5. Recent advances in managing idiopathic pulmonary fibrosis

    Article • F1000Research, November 2017, Faculty of 1000, Ltd.

    Sergio Harari, Antonella Caminati

  6. New insights in lymphangioleiomyomatosis and pulmonary Langerhans cell histiocytosis

    Article • European Respiratory Review, September 2017, European Respiratory Society (ERS)

    Sergio Harari

  7. Severe idiopathic pulmonary fibrosis: what can be done?

    Article • European Respiratory Review, September 2017, European Respiratory Society (ERS)

    Sergio Harari

  8. Rare pulmonary diseases: a common fight

    Article • European Respiratory Review, September 2017, European Respiratory Society (ERS)

    Sergio Harari

  9. Pulmonary Hypertension in Parenchymal Lung Diseases

    Article • CHEST Journal, June 2017, Elsevier

    Sergio Harari

  10. Out with the old, in with the new for theEuropean Respiratory Review

    Article • European Respiratory Review, January 2017, European Respiratory Society (ERS)

    Sergio Harari

  11. Epidemiology, survival, incidence and prevalence of idiopathic pulmonary fibrosis in the USA and Canada

    Article • European Respiratory Journal, January 2017, European Respiratory Society (ERS)

    Sergio Harari

  12. The revolution of pulmonary arterial hypertension

    Article • European Respiratory Review, November 2016, European Respiratory Society (ERS)

    Sergio Harari

  13. Data sharing: When better may be the enemy of good

    Article • European Journal of Internal Medicine, September 2016, Elsevier

    Sergio Harari

  14. Adding new perspectives to theEuropean Respiratory Review

    Article • European Respiratory Review, August 2016, European Respiratory Society (ERS)

    Sergio Harari

  15. Sirolimus Therapy for Patients With Lymphangioleiomyomatosis Leads to Loss of Chylous Ascites and Circulating LAM Cells

    Article • CHEST Journal, August 2016, Elsevier

    Sergio Harari

  16. Thoracic involvement in generalised lymphatic anomaly (or lymphangiomatosis)

    Article • European Respiratory Review, May 2016, European Respiratory Society (ERS)

    Sergio Harari

  17. Why we should care about ultra-rare disease

    Article • European Respiratory Review, May 2016, European Respiratory Society (ERS)

    Sergio Harari

  18. Faculty of 1000 evaluation for Pulmonary rehabilitation in lymphangioleiomyomatosis: a controlled clinical trial.

    Article • May 2016, Faculty of 1000, Ltd.

    Sergio Harari

  19. Toward better management of rare and orphan pulmonary diseases

    Article • European Respiratory Journal, April 2016, European Respiratory Society (ERS)

    Sergio Harari

  20. The goal is to go further and do better: but how?

    Article • European Respiratory Review, February 2016, European Respiratory Society (ERS)

    Sergio Harari

  21. Idiopathic pulmonary fibrosis: from clinical trials to real-life experiences

    Article • European Respiratory Review, August 2015, European Respiratory Society (ERS)

    Sergio Harari

  22. Smoking-related idiopathic interstitial pneumonia: A review

    Article • Respirology, July 2015, Wiley

    Sergio Harari

  23. Out-of-Proportion Pulmonary Hypertension

    Article • CHEST Journal, November 2012, Elsevier

    Sergio Harari

  24. Faculty of 1000 evaluation for Pleuroparenchymal fibroelastosis: a spectrum of histopathological and imaging phenotypes.

    Article • September 2012, Faculty of 1000, Ltd.

    Sergio Harari

  25. Bronchoscopic diagnosis of Langerhans cell histiocytosis and lymphangioleiomyomatosis

    Article • Respiratory Medicine, September 2012, Elsevier

    Sergio Harari

  26. Faculty of 1000 evaluation for Exercise performance and dynamic hyperinflation in lymphangioleiomyomatosis.

    Article • August 2012, Faculty of 1000, Ltd.

    Sergio Harari

  27. Faculty of 1000 evaluation for Use of variability in national and regional data to estimate the prevalence of lymphangioleiomyomatosis.

    Article • October 2011, Faculty of 1000, Ltd.

    Sergio Harari

  28. Faculty of 1000 evaluation for Efficacy and safety of sirolimus in lymphangioleiomyomatosis.

    Article • April 2011, Faculty of 1000, Ltd.

    Sergio Harari

  29. Pleural and pulmonary involvement in systemic lupus erythematosus

    Article • La Presse Médicale, January 2011, Elsevier

    Sergio Harari

  30. Faculty of 1000 evaluation for Elevated brain natriuretic peptide predicts mortality in interstitial lung disease.

    Article • October 2010, Faculty of 1000, Ltd.

    Sergio Harari

  31. IPF: New insight in diagnosis and prognosis

    Article • Respiratory Medicine, July 2010, Elsevier

    Sergio Harari

  32. Rare pulmonary diseases: A path to the future

    Article • Respiratory Medicine, July 2010, Elsevier

    Sergio Harari

  33. Faculty of 1000 evaluation for Pirfenidone in idiopathic pulmonary fibrosis.

    Article • June 2010, Faculty of 1000, Ltd.

    Sergio Harari

  34. Reversible Airflow Obstruction in Lymphangioleiomyomatosis

    Article • CHEST Journal, December 2009, Elsevier

    Sergio Harari

  35. Evolution of emphysema in relation to smoking

    Article • European Radiology, August 2009, Springer Science + Business Media

    Sergio Harari

  36. Exercise-induced cardiac costraint by the lungs

    Article • Respiratory Medicine CME, January 2009, Elsevier

    Sergio Harari

  37. Effect of a Gonadotrophin-Releasing Hormone Analogue on Lung Function in Lymphangioleiomyomatosis

    Article • CHEST Journal, February 2008, Elsevier

    Sergio Harari

  38. Pulmonary Langerhans’ Cell Histiocytosis

    Article • January 2007, Karger Publishers

    Sergio Harari

  39. Diffuse Cystic Lung Diseases

    Article • CHEST Journal, January 2004, Elsevier

    Sergio Harari

  40. Current Strategies in the Treatment of Invasive Aspergillus Infections in Immunocompromised Patients

    Article • Drugs, January 1999, Springer Science + Business Media

    Sergio Harari

  41. Relapsing Aspergillus Bronchitis in a Double Lung Transplant Patient, Successfully Treated With a New Oral Antimycotic Agent

    Article • CHEST Journal, March 1997, Elsevier

    Sergio Harari

  42. ABSENCE OF HYPERHOMOCYSTEINEMIA IN TEN PATIENTS WITH PRIMARY PULMONARY HYPERTENSION

    Article • Thrombosis Research, February 1997, Elsevier

    Sergio Harari

  43. Immunocytochemical Detection of Progesterone Receptors

    Article • CHEST Journal, March 1995, Elsevier

    Sergio Harari

  44. Trapianto polmonare e broncoscopia

    Article • Springer Science + Business Media

    Sergio Harari

  45. Metodiche diagnostiche endoscopiche: applicazioni nel paziente immunocompromesso

    Article • Springer Science + Business Media

    Sergio Harari